All three tenses have at least two readings, so the archetype blend applies as printed.
Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.
What did they actually do?
Has it survived what it has been through?
2 warning events since 2020; the latest 2024-01-30.
From the record
Bon Natural Life Limited's filings since 2020 show 2 warning events: a late-report notice (Form NT 10-K or NT 10-Q, 2 times, the latest 2024-01-30) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What has it actually done, year after year?
+2.2% a year over 7 filed years; profitable in 6 of 7.
From the record
Bon Natural Life Limited's 7 filed years say what it did: revenue went from $16 million in fiscal 2019 to $19 million in fiscal 2025, up 2.2% a year; it rose in 3 of 6 years; the deepest fall was 38% from fiscal 2022 to fiscal 2025; net income was positive in 6 of 7 of those years (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How has it treated the people who own it?
Share count grew 334.4% a year. 0% of cash flow returned. Insiders: 0 sales, 0 purchases.
From the record
Over the 3 fiscal years to 2025-09-30, Bon Natural Life Limited's diluted share count grew about 334.4% a year, and dividends and buybacks returned about 0% of its net income over 3 years (its filed statements). Its officers and directors filed 0 sales and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are they doing right now?
Is it financially healthy right now?
ROE -3%: lost 3¢ per shareholder dollar. Leverage 32%: owes 32¢ per asset dollar.
From the record
Return on equity: in the fiscal year ended 2025-09-30, Bon Natural Life Limited lost about 3 cents for every dollar of shareholders' money, and gross profitability: its products earned about 5 cents per dollar of everything the company owns. Leverage: it owed about 32 cents per dollar of assets, and net share issuance: its share count grew 2766.6% over the year (the filed statements).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How strong is its position in its industry?
bottom 24% of 18 in its family; net margin -10.7%.
From the record
Bon Natural Life Limited's standing among 18 graded names in its industry family: revenue of $19 million in fiscal 2025 ranks in the bottom 18% by size; a net margin of -10.7% ranks in the top 47%; revenue growth of -14.5% a year over the last 3 filed years ranks in the bottom 3% (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are the people in charge doing?
SI estimate 5.0/10, confidence 20 of 100 (family median).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: Bon Natural Life Limited's leadership is put at 5.0 of 10 with a confidence of 20 of 100, because it files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-04-10 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 7 months and cannot see past it; a floor under five years is not read as years in charge, so the desk assumes the typical reading of its industry family, the median of 12 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.
What are they set up to do next?
How much room does it have to grow?
bottom 45% of 18 in its family for room to expand.
From the record
Bon Natural Life Limited's room to grow, from the newest filed statements (fiscal 2025): cash of $6 million against debt of $2 million leaves 5.1% of its assets as net cash, bottom 29% of its family; cash from operations less capital spending is 0.7% of revenue (top 47%); a gross margin of 20.8% (bottom 21%); research spending of 4% of revenue (top 23%) (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What could actually drive growth from here?
bottom 40% of 18 in its family for growth drivers.
From the record
Bon Natural Life Limited's growth drivers, from the filed years to fiscal 2025: revenue grew -14.5% a year over the last three filed years against 2.2% over all 7, slowing (top 47% of its family); the newest year grew -21.7% (bottom 3%); research spending grew 21.1% a year (top 4%); capital spending grew -37.3% a year (bottom 9%) (its annual reports). Bon Natural Life Limited reported 3 product lines in fiscal 2025: Fragrance Compounds at $8 million (43%), Bioactive Food Ingredients at $7 million (39%), Health Supplements Solid Drinks at $3 million (18%); 1 of 3 grew against the year before (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Did its newest year beat what its own record pointed to?
bottom 19% of 18 in its family for expectations against reality.
From the record
Bon Natural Life Limited's newest year against its own record: revenue of $19 million in fiscal 2025 came in 12.3% below the $21 million its prior three years' pace pointed to (bottom 25% of its family); net income of $2 million against a prior three-year average of $4 million (bottom 19%); a net margin of -10.7% against 12.7% before (bottom 14%) (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made